Tag: Targeted therapy for lung cancer
Roche Lung Cancer Study: Immunotherapy Failures and Drug Target Questions
Roche, a pharmaceutical company, recently announced that an experimental cancer treatment they were working on, called tiragolumab, did not improve survival rates in a major lung cancer study. The study, known as SKYSCRAPER-01, involved...